A nurse is teaching a client who has a new prescription for isoniazid. Which of the following information should the nurse include in the teaching?
"You will need to have frequent sputum tests to monitor the effectiveness of the medication."
"You will be able to stop taking this medication after a month."
"You can take an antacid containing aluminum at the same time as this medication."
"You can expect to have constipation while taking this medication."
The Correct Answer is A
A. Frequent sputum tests may be needed to monitor the effectiveness of isoniazid, particularly in assessing the resolution of tuberculosis infection.
B. Isoniazid is usually prescribed for a minimum of six months for tuberculosis treatment, not just a month. Thus, stopping after one month is incorrect.
C. Antacids containing aluminum should not be taken concurrently with isoniazid, as they can interfere with the absorption of the medication, reducing its effectiveness.
D. Constipation is not a common side effect of isoniazid. The more frequent side effects include peripheral neuropathy and liver toxicity, making this statement incorrect.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is ["A","D"]
Explanation
A. Terazosin is indicated for the treatment of hypertension as it works by relaxing blood vessels, leading to lower blood pressure.
B. Terazosin is not indicated for heart failure; other medications are typically used to manage this condition.
C. Male pattern baldness is treated with other medications, such as finasteride, rather than terazosin.
D. Terazosin is also indicated for benign prostatic hypertrophy (BPH), as it helps alleviate urinary symptoms associated with this condition by relaxing the smooth muscles in the prostate and bladder neck.
E. Terazosin is not indicated for erectile dysfunction; it is primarily used for hypertension and BPH.
Correct Answer is C
Explanation
A. Sargramostim is a granulocyte-macrophage colony-stimulating factor (GM-CSF) used to stimulate the production of white blood cells but is not specifically indicated for anemia.
B. Filgrastim is a granulocyte colony-stimulating factor (G-CSF) that increases white blood cell counts and is not used for treating anemia.
C. Epoetin is an erythropoiesis-stimulating agent that stimulates red blood cell production, making it the appropriate choice for treating chemotherapy-induced anemia.
D. Romiplostim is a thrombopoietin receptor agonist used to treat thrombocytopenia (low platelet count) and is not indicated for anemia.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.